Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…
(877) 363-6376
HELPLINE
Join us to learn more about financial assistance programs for patients and caregivers traveling to obtain treatment or enroll in a clinical trial; and funding…
“We are at a point where in the next few years we’re going to have a lot more options for our patients,” said Dr. Hedy…
When John Lewis and his wife saw a post about the Foundation’s Travel Grant Program (a program providing financial assistance for travel for mesothelioma treatment)…
Dr. Raffit Hassan of the National Cancer Institute joins us for a conversation about his study called “Tissue Procurement and Natural History Study of Patients…
Jessica Blackford-Cleeton and Rich Mosca, both members of the mesothelioma community, recently participated in the evaluation of research proposals for funding through the Congressionally Directed…
On behalf of the Board of Directors of the Mesothelioma Applied Research Foundation, we are excited to introduce you to the organization’s new Executive Director,…
Mary Hesdorffer, Mesothelioma Applied Research Foundation sits down for a conversation with Raphael Bueno, MD, of Harvard Medical School and Brigham and Women’s Hospital in…
Dr. William Breen of the Mayo Clinic joins our executive director and mesothelioma expert Mary Hesdorffer, NP in a conversation about Dr. Breen’s study exploring…
Today, the Mesothelioma Applied Research Foundation announced the selection and funding of three new research awards for mesothelioma research. The three grants, each at $100,000,…